View Cart  

Supplements Lead to More Burdens Than Standard Filings, Tufts Finds

NDA and BLA supplements have created more headaches for pharma companies than standard new drug or biologic applications, finds a new study from the Tufts Center for the Study of Drug Development.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00